Abstract
This review discusses progress made over the past 10+ years in elucidating the properties, regulation, and function of protein tyrosine phosphatase alpha (PTPα). It is apparent from studies in knockout mice and diverse cell lines that the major action of PTPα is as a positive regulator of src and src family kinases. PTPα dephosphorylates and activates src. In this manner it affects transformation and tumourigenesis, inhibition of proliferation and cell cycle arrest, mitotic activation of src, integrin signaling, neuronal differentiation and outgrowth, and ion channel activity. PTPα may well modulate additional processes, including insulin signaling, and have other targets besides src family kinases. As an important modulator of several specific cell signaling pathways, PTPα has promise as a target for drug discovery. Continued research on the physiological and pathological activities of PTPα is necessary to define the therapeutic potential of PTPα-directed pharmacologicals.
Keywords: Protein Tyrosine Phosphatase, tumourigenesis
Current Topics in Medicinal Chemistry
Title: Protein Tyrosine Phosphatase α (PTPα): A Src Family Kinase Activator and Mediator of Multiple Biological Effects
Volume: 3 Issue: 7
Author(s): Catherine J. Pallen
Affiliation:
Keywords: Protein Tyrosine Phosphatase, tumourigenesis
Abstract: This review discusses progress made over the past 10+ years in elucidating the properties, regulation, and function of protein tyrosine phosphatase alpha (PTPα). It is apparent from studies in knockout mice and diverse cell lines that the major action of PTPα is as a positive regulator of src and src family kinases. PTPα dephosphorylates and activates src. In this manner it affects transformation and tumourigenesis, inhibition of proliferation and cell cycle arrest, mitotic activation of src, integrin signaling, neuronal differentiation and outgrowth, and ion channel activity. PTPα may well modulate additional processes, including insulin signaling, and have other targets besides src family kinases. As an important modulator of several specific cell signaling pathways, PTPα has promise as a target for drug discovery. Continued research on the physiological and pathological activities of PTPα is necessary to define the therapeutic potential of PTPα-directed pharmacologicals.
Export Options
About this article
Cite this article as:
Pallen J. Catherine, Protein Tyrosine Phosphatase α (PTPα): A Src Family Kinase Activator and Mediator of Multiple Biological Effects, Current Topics in Medicinal Chemistry 2003; 3 (7) . https://dx.doi.org/10.2174/1568026033452320
DOI https://dx.doi.org/10.2174/1568026033452320 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Growth Factor Delivery to Re-Engineer Periodontal Tissues
Current Pharmaceutical Biotechnology Plasma Infusions into Porcine Cerebral White Matter Induce Early Edema, Oxidative Stress, Pro-Inflammatory Cytokine Gene Expression and DNA Fragmentation: Implications for White Matter Injury with Increased Blood- Brain-Barrier Permeability
Current Neurovascular Research Role of Polyglycine Repeats in the Regulation of Glycogen Synthase Kinase Activity
Protein & Peptide Letters Ethyl Pyruvate: A Novel Treatment for Sepsis
Current Drug Targets Anionic Polysaccharide Hydrogels with Charges Provided by the Polysaccharide or the Crosslinking Agent
Drug Delivery Letters Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Current Vascular Pharmacology Secondary Metabolites in the Treatment of Diabetes Mellitus: A Paradigm Shift
Current Drug Metabolism Overview of Binding Free Energy Calculation Techniques for Elucidation of Biological Processes and for Drug Discovery
Medicinal Chemistry A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies
Clinical Cancer Drugs Clinical Trials for Neuroprotection in ALS
CNS & Neurological Disorders - Drug Targets The Role of Physical Activity in the Development and Prevention of Overweight and Obesity in Childhood
Current Nutrition & Food Science Calcifediol – More than the Stepchild of CKD-MBD Therapy?
Current Vascular Pharmacology Purinergic Signalling and Endothelium
Current Vascular Pharmacology Vascular Disease and Insulin-Like Growth Factor-1
Vascular Disease Prevention (Discontinued) Getting to Know the Cast - Cellular Interactions and Signaling at the Neurovascular Unit
Current Pharmaceutical Design A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents
Mini-Reviews in Medicinal Chemistry Chemistry and Biology of Cyperus scariosus: An Overview
Current Chemical Biology Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Managing Cardiovascular Risk Factors without Medications: What is the Evidence?
Cardiovascular & Hematological Agents in Medicinal Chemistry Mastering the Treatment of Diabetes Mellitus Type 1 in Childhood and Adolescence
Current Pediatric Reviews